1887

Abstract

Identifying transient low-level hepatitis B (HBV) surface antigen (sAg) post-vaccination is a well-established phenomenon in haemodialysis patients. These results create a clinical conundrum; should patients be deemed potentially infectious, requiring further testing and heightened infection control precautions, or should negligible risk be assumed? National guidance covering this scenario is lacking; therefore we conducted a survey of the clinical practice of UK virology departments. Thirty-six laboratories were contacted and 17 responses received (47 %). Eleven responders had observed sAg positivity post-vaccination, for a maximum duration of 3 weeks. Clinical management was highly variable. Only 3 hospitals had specific written policies, with others following an internal consensus or a standard protocol for sAg positive patients without recent vaccine. Further testing consisted of HBV serology (3/11), HBV PCR (1/11) or PCR and serology (7/11). Three departments were highly risk averse, recommending universal isolation with dedicated dialysis machines. Two departments did not advise additional precautions and 5 based decisions on risk factors e.g. foreign travel. Heightened precautions were stopped on the basis of negative serology (1/11), PCR (5/11) or serology and PCR (2/11). To summarise, vaccine-derived sAg positivity is commonly encountered on haemodialysis units. Recommendations on the interval between vaccination and testing would alleviate the issue, with this study suggesting a minimum of 3 weeks. Infection control precautions varied considerably. In most cases, patients are risk assessed for isolation as a minimum; however this may depend on local expertise and the availability of isolation facilities. It is clear that national guidance would standardise patient care.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.ac2019.po0315
2019-04-08
2022-05-19
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.ac2019.po0315
Loading

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error